-
Mashup Score: 0Protection and Antibody Levels 35 Years after Primary Series with Hepatitis B Vaccine and Response to a Booster Dose - 2 year(s) ago
Background The duration of protection from hepatitis B vaccination in children and adults is not known. In 1981, we used three doses of plasma-derived hepatitis B vaccine to immunize a cohort of 157…
Source: AASLDCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 2E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants - 2 year(s) ago
Background and Aims The increased frequency of urinary tract infections in patients with primary biliary cholangitis (PBC) and the cross-reactivity between the lipoyl domains (LD) of human pyruvate …
Source: AASLDCategories: Gastroenterology, Latest HeadlinesTweet-
Febrero @HEP_Journal E. coli y la etiología de la #CBP humana: anticuerpos antimitocondriales y determinantes de propagación #LiverTwitter https://t.co/18WVDe4wYe https://t.co/6UPDidB2I1
-
February @HEP_Journal E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants #LiverTwitter https://t.co/18WVDe4wYe https://t.co/IsRMKmVbFP
-
-
Mashup Score: 13
Steady progress over four decades toward understanding the pathogenesis and clinical consequences of hepatic fibrosis has led to the expectation of effective antifibrotic drugs, yet none has been app…
Source: AASLDCategories: Gastroenterology, Latest HeadlinesTweet-
Febrero @HEP_Journal Fibrosis hepática 2022: Necesidades insatisfechas y un plan para el futuro Scott L. #Friedman y Massimo #Pinzani #LiverTwitter https://t.co/pm6OYDw7kx https://t.co/Y7Thjvre5P
-
February @HEP_Journal Hepatic fibrosis 2022: Unmet needs and a blueprint for the future Scott L. #Friedman & Massimo #Pinzani #LiverTwitter https://t.co/pm6OYDNIc5 https://t.co/BUwi5NtYon
-
-
Mashup Score: 2Autoimmune hepatitis in pregnancy: pearls and pitfalls - 2 year(s) ago
Autoimmune hepatitis (AIH) in pregnancy has many unique considerations. Evidence provided from single centre studies with patient level data and nationwide population studies provide valuable insight…
Source: AASLDCategories: Gastroenterology, Latest HeadlinesTweet-
RT @joaprimo: Autoimmune hepatitis in pregnancy: pearls and pitfalls. @MichaelHenegha8 @HEP_Journal https://t.co/tZDWfqUBbs #livertwitter…
-
-
Mashup Score: 7
Background and Aims Cholangiocarcinoma (CCA) is a deadly and highly therapy-refractory cancer of the bile ducts, with early results from immune checkpoint blockade trials showing limited responses. …
Source: AASLDCategories: Gastroenterology, Latest HeadlinesTweet-
#HEP_Highlights Febrero: Carapeto et al identificaron que las células inmunitarias y las moléculas del checkpoint están ⬇️ en el centro del tumor en comparación con el margen invasivo en el CCA TIME. #LiverTwitter https://t.co/p1XrLIS7GH
-
#HEP_Highlights February: Carapeto et al identified that both immune cell and checkpoint molecule expression were ⬇️ in the tumor center compared to the invasive margin in the CCA TIME. A “cold” TIME was associated with poor patient survival. #LiverTwitter https://t.co/p1XrLIS7GH
-
-
Mashup Score: 0Optimizing hepatitis B virus screening in the United States using a simple demographics‐based model - 2 year(s) ago
Background and Aims Chronic hepatitis B (CHB) affects >290 million persons globally, and only 10% have been diagnosed, presenting a severe gap that must be addressed. We developed logistic regressio…
Source: AASLDCategories: Gastroenterology, Latest HeadlinesTweet-
Optimización de la detección del virus de la #hepatitisB en los Estados Unidos mediante un modelo simple basado en datos demográficos #LiverTwitter https://t.co/OjF0AFJ6ce https://t.co/hV4TtKwmEQ
-
Optimizing #hepatitisB virus screening in the United States using a simple demographics‐based model #LiverTwitter https://t.co/OjF0AFJ6ce https://t.co/jrEgQr7sur
-
-
Mashup Score: 3
Cholangiocarcinoma (CCA) represents the second-most common primary liver malignancy after HCC and has risen in incidence globally in the past decades. Intrahepatic cholangiocarcinoma (iCCA) comprises…
Source: AASLDCategories: Gastroenterology, Latest HeadlinesTweet-
Febrero @HEP_Journal: Trasplante hepático para colangiocarcinoma intrahepático: ¿Listo para el horario estelar? @sapisochin #TommyIvanics @JulieHeimbach #LiverTwitter https://t.co/vNaXifOH3d https://t.co/3BCCywiDMG
-
February @HEP_Journal: Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time? @sapisochin #TommyIvanics @JulieHeimbach #LiverTwitter https://t.co/vNaXifOH3d https://t.co/4PH2sh6Kjs
-
-
Mashup Score: 5Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition–associated cholestasis in mice - 2 year(s) ago
Background and Aims Parenteral nutrition (PN)–associated cholestasis (PNAC) complicates the care of patients with intestinal failure. In PNAC, phytosterol containing PN synergizes with intestinal in…
Source: AASLDCategories: Gastroenterology, Latest HeadlinesTweet-
#HEP_Highlights Febrero: La colestasis asociada a nutrición parenteral (PNAC) es una complicación grave. En un modelo de ratón, Kasmi et al. encontraron que un agonista de FXR disminuyó el daño hepático y la colestasis. #LiverTwitter https://t.co/gqmV9ONr40
-
#HEP_Highlights February: Parenteral nutrition-associated cholestasis (PNAC) is a severe complication. In a mouse model, Kasmi et al. found that an FXR agonist decreased hepatic injury and cholestasis. #LiverTwitter https://t.co/gqmV9OvQcs
-
-
Mashup Score: 0The Impact of Nonalcoholic Fatty Liver Disease on the Outcomes of Coronavirus Disease 2019 Infection - 2 year(s) ago
Content available: Audio Recording
Source: AASLDCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Learn about the impact of nonalcoholic fatty liver disease on the outcomes of #COVID19 infection in this new article by Joseph Asemota & Farshad Aduli in @CLD_Learning. Get free access now: https://t.co/FfVnMSl5HB @AASLDtweets @NancyReau #LiverTwitter #NAFLD https://t.co/S0AKWyIx9I
-
-
Mashup Score: 5AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis - 2 year(s) ago
–
Source: AASLDCategories: Gastroenterology, Latest HeadlinesTweet-
Acceda a la #guía práctica más reciente disponible en @AASLDtweets: #Cuidados paliativos y manejo basado en síntomas en #cirrosis descompensada. #LiverTwitter @ArpanPatelMD @NnekaUfereMD @KanwalFasiha https://t.co/ZeQ3udySsh
-
Access the newest practice #guidance available from @AASLDtweets: #Palliative care and symptom-based management in decompensated #cirrhosis. #LiverTwitter @ArpanPatelMD @NnekaUfereMD @KanwalFasiha https://t.co/ZeQ3udhh3H
-
A @CDCgov team conducted an analysis of the protection and antibody levels 35 years after primary series with #HepatitisB vaccine and response to a booster dose 💉, and concluded that booster doses are not needed in the general population at this time. https://t.co/Y19sUMZpb0 https://t.co/bISxh3pSby